[1] Thomas, C. R., Wright, C. D., & Loehrer, P. J. 1999. Thymoma: state of the art. J Clin Oncol, 17(7), 2280-2289. doi: 10.1200/JCO.1999.17.7.2280
[2] Jhaveri, K. D., Shah, H. H., Calderon, K., Campenot, E. S., & Radhakrishnan, J. 2013. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int, 84(1), 34-44. doi: 10.1038/ki.2012.484
[3] Karras, A., de Montpreville, V., Fakhouri, F., Grünfeld, J. P., & Lesavre, P. 2005. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol. Dial. Transplant., 20(6), 1075-1082.
[4] Kuwata, T., Iwata, T., & Iwanami, T. 2012. Post-thymectomy myasthenia gravis with an episode of Osserman stage III. J Surg Case Rep, 2012(5), 3. doi: 10.1093/jscr/2012.5.3
[5] Nakajima, J., Murakawa, T., Fukami, T., Sano, A., Takamoto, S., & Ohtsu, H. 2008. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg, 86(3), 941-945. doi: 10.1016/j.athoracsur.2008.04.070
[6] Yamada, Y., Yoshida, S., Iwata, T., et al. 2015. Risk factors for developing postthymectomy myasthenia gravis in thymoma patients. Ann Thorac Surg, 99(3), 1013-1019. doi: 10.1016/j.athoracsur.2014.10.068
[7] Lippner, E. A., Lewis, D. B., Robinson, W. H., & Katsumoto, T. R. 2019. Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies. Curr Treat Options Oncol, 20(7), 62. doi: 10.1007/s11864-019-0661-2
[8] Yamauchi, J., Ubara, Y., & Suwabe, T. 2011. Focal segmental glomerulosclerosis associated with invasive thymoma. Ther Apher Dial, 15(2), 210-211. doi: 10.1111/j.1744-9987.2010.00871.x
[9] Matsuda, M., Miki, J., Tabata, K., Ikezoe, M., Nishizawa, N., & Ishigame, H. 2000. Myasthenia gravis with membranous nephropathy, successfully treated with extended total thymectomy. Intern Med, 39(6), 490-494. doi: 10.2169/internalmedicine.39.490
[10] Rena, O., Papalia, E., Maggi, G., et al. 2005. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer, 50(1), 59-66. doi: 10.1016/j.lungcan.2005.05.009
[11] Masaoka, A., Monden, Y., Nakahara, K., & Tanioka, T. 1981. Follow-up study of thymomas with special reference to their clinical stages. Cancer, 48(11), 2485-2492. doi: 10.1002/1097-0142(19811201)48:11<2485::aid-cncr2820481123>3.0.co;2-r
[12] Davison, A. M. 2001. Renal diseases associated with malignancies. Nephrol Dial Transplant, 16 Suppl 6, 13-14. doi: 10.1093/ndt/16.suppl_6.13
[13] Kisand, K., Lilic, D., Casanova, J. L., Peterson, P., Meager, A., & Willcox, N. 2011. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol, 41(6), 1517-1527. doi: 10.1002/eji.201041253
[14] Hoffacker, V., Schultz, A., Tiesinga, J. J., et al. 2000. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood, 96(12), 3872-3879.
[15] Weksler, B., & Lu, B. 2014. Alterations of the immune system in thymic malignancies. J Thorac Oncol, 9(9 Suppl 2), S137-142. doi: 10.1097/JTO.0000000000000299
[16] Posner, M. R., Prout, M. N., & Berk, S. 1980. Thymoma and the nephrotic syndrome: a report of a case. Cancer, 45(2), 387-391. doi: 10.1002/1097-0142(19800115)45:2<387::aid-cncr2820450233>3.0.co;2-z
[17] Nie, P., Chen, R., Luo, M., et al. 2019. Clinical and Pathological Analysis of 4910 Patients Who Received Renal Biopsies at a Single Center in Northeast China. Biomed Res Int, 2019, 6869179. doi: 10.1155/2019/6869179
[18] Simon, P., Ramee, M. P., Boulahrouz, R., et al. 2004. Epidemiologic data of primary glomerular diseases in western France. Kidney Int, 66(3), 905-908. doi: 10.1111/j.1523-1755.2004.00834.x
[19] Kilis-Pstrusinska, K., Medynska, A., Zwolinska, D., & Dobaczewski, G. 2008. Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome--a case report. Pediatr Nephrol, 23(6), 1001-1003. doi: 10.1007/s00467-007-0666-0
[20] Yoo, S. H., Kim, H. J., Kim, J. H., et al. 2017. Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy. Medicine (Baltimore), 96(1), e5408. doi: 10.1097/md.0000000000005408